Nanoco Group Texas trial stay lifted

Nanoco Group plc (LON:NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform, has announced an update to its litigation against Samsung for the willful infringement of the Group’s IP.

His Honour, Judge Gilstrap, has lifted the stay on the trial to be held in Texas. The Judge rejected Samsung’s request for a further delay and ruled in favour of Nanoco to lift the stay. The pre-trial conference date has been set for 16 August 2022 and jury selection has been set for 12 September 2022. The trial is expected to follow shortly thereafter.

Brian Tenner, Chief Executive Officer of Nanoco Group plc, said:

“We were ready and confident to go to trial in September 2021. We won all 47 of our claims examined by the Patent Trial and Appeal Board in May 2022. This settled the issue of validity emphatically in Nanoco’s favour. So we are ready and even more confident to go to trial in September 2022.

“The trial can now focus on the issue of Samsung’s alleged wilful infringement and the appropriate level of damages. We remain convinced of the strength of our case and that a favourable trial outcome will deliver a substantial inflection point for Nanoco’s prospects and shareholder value.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Nanoco Group PLC

More articles like this

Nanoco Group PLC

Quantum Dots could revolutionise your portfolio

Unlock the potential of quantum dots – microscopic particles revolutionizing industries with vibrant displays, efficient sensors, and advanced medical tools. Experience the economic opportunities with Nanoco Group PLC.

Nanoco Group PLC

QDs: Harnessing Quantum Confinement

Explore the groundbreaking research on colloidal quantum dots and their ability to control photochemical reactions through quantum coherence.

Nanoco Group PLC

The promise of Quantum Dots

Quantum dots (QDs) represent a significant advancement in nanotechnology, finding applications across diverse fields. In bioimaging, their small size enables them to access almost any part of the body, making them ideal for tasks like medical